HALOPERIDOL DECANOATE INJECTION 100 MG — DIN 02383756
HALOPERIDOL (HALOPERIDOL DECANOATE) : 100 MG · STRIDES PHARMA CANADA INC · SOLUTION · wholesale supply in Canada
Health Canada status: APPROVED
What is HALOPERIDOL DECANOATE INJECTION?
HALOPERIDOL DECANOATE INJECTION 100 MG contains HALOPERIDOL (HALOPERIDOL DECANOATE) : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02383756, held by STRIDES PHARMA CANADA INC, supplied as SOLUTION for INTRAMUSCULAR administration. Health Canada currently lists it as approved, status dated 27-May-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A). This DIN is not currently being marketed in Canada, so it is sourced to order where a compliant route exists rather than held in stock.
How much does Haloperidol cost around the world?
Haloperidol is listed on 15 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Bahrain publishes a retail (max); Brazil publishes a preco fabrica (ex-factory ceiling). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| United States | acquisition | 6 | 84 | USD███.██ |
| Brazil | preco fabrica (ex-factory ceiling) | 6 | 20 | BRL███.██ |
| Saudi Arabia | public | 11 | 13 | SAR███.██ |
| Australia | ex-manufacturer | 2 | 10 | AUD███.██ |
| South Africa | single exit price | 8 | 10 | ZAR███.██ |
| Spain | PVP con IVA (public price) | 7 | 7 | EUR███.██ |
| United Kingdom | hospital | 7 | 7 | GBP███.██ |
| Greece | producer price (ex-factory) | 7 | 7 | EUR███.██ |
| Romania | max producer price | 7 | 7 | RON███.██ |
| Lebanon | public price (USD, Decision 119/1) | 1 | 4 | USD███.██ |
| Morocco | PPV (public price) | 3 | 4 | MAD███.██ |
| Hungary | producer price (ex-factory) | 2 | 2 | HUF███.██ |
| Norway | max AUP (pharmacy retail) | 1 | 2 | NOK███.██ |
| Slovakia | categorised final price | 2 | 2 | EUR███.██ |
| Bahrain | retail (max) | 1 | 1 | BHD███.██ |
180 pack listings across 71 brand entries and 14 price bases, refreshed 08 Sep 2026. Ranges span every Haloperidol pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Haloperidol in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
17 holders have a Canadian DIN containing Haloperidol, across 51 DINs, of which 9 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| TEVA CANADA LIMITED | 6 | 5 | TEVA-HALOPERIDOL | Sourceable in Canada |
| SANDOZ CANADA INCORPORATED | 3 | 2 | HALOPERIDOL INJ 5MG/ML USP, HALOPERIDOL LA | Sourceable in Canada |
| OMEGA LABORATORIES LIMITED | 3 | 1 | HALOPERIDOL INJECTION, HALOPERIDOL-LA OMEGA | Sourceable in Canada |
| FRESENIUS KABI CANADA LTD | 1 | 1 | HALOPERIDOL INJECTION, USP | Sourceable in Canada |
| APOTEX INC | 8 | 0 | APO HALOPERIDOL TAB 0.5MG, APO HALOPERIDOL TAB 1MG, APO-HALOPERIDOL LA INJECTABLE, APO-HALOPERIDOL LIQ 2MG/ML, APO-HALOPERIDOL TAB 10MG, APO-HALOPERIDOL TAB 2MG, APO-HALOPERIDOL TAB 5MG | No marketed DIN |
| RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED | 6 | 0 | RATIO-HALOPERIDOL 2MG/ML, RATIO-HALOPERIDOL TAB 0.5MG, RATIO-HALOPERIDOL TAB 10MG, RATIO-HALOPERIDOL TAB 1MG, RATIO-HALOPERIDOL TAB 2MG, RATIO-HALOPERIDOL TAB 5MG | No marketed DIN |
| PRO DOC LIMITEE | 5 | 0 | HALOPERIDOL TAB 0.5MG, HALOPERIDOL TAB 1MG, HALOPERIDOL TAB 2MG, HALOPERIDOL TAB 5MG, HALOPERIDOL-10 TAB 10MG | No marketed DIN |
| NOVOPHARM LIMITED | 3 | 0 | HALOPERIDOL LONG ACTING, NOVO-PERIDOL ORAL SOLN 2MG/ML | No marketed DIN |
| PHARMASCIENCE INC | 3 | 0 | PMS-HALOPERIDOL SOLN 2MG/ML, PMS-HALOPERIDOL-LA | No marketed DIN |
| DAVID BULL LABORATORIES (PTY) LTD. | 2 | 0 | HALOPERIDOL DECANOATE INJ. LIQ IM 100MG/ML, HALOPERIDOL DECANOATE INJ. LIQ IM 50MG/ML | No marketed DIN |
| JANSSEN INC | 2 | 0 | HALDOL LA INJ 100MG/ML, HALDOL LA INJ 50MG/ML | No marketed DIN |
| RHODIAPHARM INC | 2 | 0 | RHO-HALOPERIDOL DECANOATE INJ.-IM 100MG/ML, RHO-HALOPERIDOL DECANOATE INJ.-IM 50MG/ML | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 100 MG |
|---|---|
| Dosage form | SOLUTION |
| Route | INTRAMUSCULAR |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation.
Substance and classification
| Active substance | Haloperidol |
|---|---|
| ATC code | N05AD01 |
| AHFS class | 84:80.00 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02383756 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2383756 |
| Brand name | HALOPERIDOL DECANOATE INJECTION |
| Generic / active ingredient | HALOPERIDOL (HALOPERIDOL DECANOATE) : 100 MG |
| Market authorization holder | STRIDES PHARMA CANADA INC |
| Health Canada schedule | Prescription |
| ATC code | N05AD01 |
| ATC anatomical main group | N — Nervous system |
| ATC therapeutic subgroup | N05AD |
| Current status | APPROVED |
| Status date | 27-May-2020 |
| Original market date | 2013-02-15 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
Is Haloperidol in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by OMEGA LABORATORIES LIMITED, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
9 of 51 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| HALOPERIDOL INJ 5MG/ML USP | 5 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED | 00808652 |
| HALOPERIDOL INJECTION | 5 MG | SOLUTION | OMEGA LABORATORIES LIMITED | MARKETED | 02366010 |
| HALOPERIDOL INJECTION, USP | 5 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED | 02406411 |
| HALOPERIDOL LA | 100 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED | 02130300 |
| TEVA-HALOPERIDOL | 2 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 00363669 |
| TEVA-HALOPERIDOL | 10 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 00713449 |
| TEVA-HALOPERIDOL | 5 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 00363650 |
| TEVA-HALOPERIDOL | 1 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 00363677 |
| TEVA-HALOPERIDOL | 0.5 MG | TABLET | TEVA CANADA LIMITED | MARKETED | 00363685 |
| APO HALOPERIDOL TAB 0.5MG | .5 MG | TABLET | APOTEX INC | DORMANT | 00396796 |
2 · Same class — other molecules in ATC N05AD
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Haloperidol | APO HALOPERIDOL TAB 0.5MG · APO HALOPERIDOL TAB 1MG · APO-HALOPERIDOL LA INJECTABLE · APO-HALOPERIDOL LIQ 2MG/ML · APO-HALOPERIDOL TAB 10MG · APO-HALOPERIDOL TAB 2MG · APO-HALOPERIDOL TAB 5MG · HALDOL INJECTION 5MG/ML · HALDOL LA INJ 100MG/ML · HALDOL LA INJ 50MG/ML · HALOPERIDOL DECANOATE INJ. LIQ IM 100MG/ML · HALOPERIDOL DECANOATE INJ. LIQ IM 50MG/ML · HALOPERIDOL DECANOATE INJECTION · HALOPERIDOL INJ 5MG/ML USP · HALOPERIDOL INJECTION · HALOPERIDOL INJECTION, USP · HALOPERIDOL LA · HALOPERIDOL LONG ACTING · HALOPERIDOL TAB 0.5MG · HALOPERIDOL TAB 1MG · HALOPERIDOL TAB 2MG · HALOPERIDOL TAB 5MG · HALOPERIDOL-10 TAB 10MG · HALOPERIDOL-LA OMEGA · NOVO-PERIDOL ORAL SOLN 2MG/ML · PMS-HALOPERIDOL SOLN 2MG/ML · PMS-HALOPERIDOL-LA · RATIO-HALOPERIDOL 2MG/ML · RATIO-HALOPERIDOL TAB 0.5MG · RATIO-HALOPERIDOL TAB 10MG · RATIO-HALOPERIDOL TAB 1MG · RATIO-HALOPERIDOL TAB 2MG · RATIO-HALOPERIDOL TAB 5MG · RHO-HALOPERIDOL DECANOATE INJ.-IM 100MG/ML · RHO-HALOPERIDOL DECANOATE INJ.-IM 50MG/ML · TEVA-HALOPERIDOL | 51 | 9 | Yes |
| Droperidol | DROPERIDOL INJECTION · DROPERIDOL INJECTION USP 2.5MG/ML | 2 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC N05A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| N05AH | Asenapine · Clozapine · Loxapine · Olanzapine · Quetiapine | 589 | 220 |
| N05AX | Aripiprazole · Brexpiprazole · Cariprazine · Paliperidone · Risperidone | 352 | 175 |
| N05AE | Lurasidone · Ziprasidone | 60 | 41 |
| N05AB | Fluphenazine · Perphenazine · Prochlorperazine · Thioproperazine · Trifluoperazine | 104 | 10 |
| N05AF | Flupentixol · Tiotixene · Zuclopenthixol | 25 | 8 |
| N05AA | Chlorpromazine · Levomepromazine · Promazine | 51 | 8 |
| N05AN | Lithium | 26 | 7 |
| N05AC | Mesoridazine · Periciazine · Pipotiazine · Thioridazine | 32 | 3 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is HALOPERIDOL DECANOATE INJECTION called?
The same molecule, Haloperidol, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| HALOPERIDOL | Latin | Brazil, Lebanon, Morocco |
| Serenace | Latin | Australia, Saudi Arabia |
| Haldol | Latin | Brazil, Norway |
| HALO | Latin | Brazil |
| HALOPERIDOL MEDSURGE | Latin | Australia |
| UNI HALOPER | Latin | Brazil |
| FURP-HALOPERIDOL | Latin | Brazil |
| HALDOL FORT | Latin | Morocco |
| HALOGOL | Latin | Bahrain |
| Haloperidol ALH | Latin | Saudi Arabia |
| Haloperidol-Richter | Latin | Slovakia |
| HYPORIDROL | Latin | Brazil |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.